Literature DB >> 34289375

Cardiovascular disease in diabetes, beyond glucose.

Robert H Eckel1, Karin E Bornfeldt2, Ira J Goldberg3.   

Abstract

Despite the decades-old knowledge that diabetes mellitus is a major risk factor for cardiovascular disease, the reasons for this association are only partially understood. While this association is true for both type 1 and type 2 diabetes, different pathophysiological processes may be responsible. Lipids and other risk factors are indeed important, whereas the role of glucose is less clear. This lack of clarity stems from clinical trials that do not unambiguously show that intensive glycemic control reduces cardiovascular events. Animal models have provided mechanisms that link diabetes to increased atherosclerosis, and evidence consistent with the importance of factors beyond hyperglycemia has emerged. We review clinical, pathological, and animal studies exploring the pathogenesis of atherosclerosis in humans living with diabetes and in mouse models of diabetes. An increased effort to identify risk factors beyond glucose is now needed to prevent the increased cardiovascular disease risk associated with diabetes.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34289375      PMCID: PMC8411849          DOI: 10.1016/j.cmet.2021.07.001

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   31.373


  315 in total

1.  Long-term effects of intensive glucose lowering on cardiovascular outcomes.

Authors:  Hertzel C Gerstein; Michael E Miller; Saul Genuth; Faramarz Ismail-Beigi; John B Buse; David C Goff; Jeffrey L Probstfield; William C Cushman; Henry N Ginsberg; J Thomas Bigger; Richard H Grimm; Robert P Byington; Yves D Rosenberg; William T Friedewald
Journal:  N Engl J Med       Date:  2011-03-03       Impact factor: 91.245

2.  Sex-specific differences in insulin resistance in type 1 diabetes: The CACTI cohort.

Authors:  Richard J Millstein; Laura L Pyle; Bryan C Bergman; Robert H Eckel; David M Maahs; Marian J Rewers; Irene E Schauer; Janet K Snell-Bergeon
Journal:  J Diabetes Complications       Date:  2018-01-10       Impact factor: 2.852

3.  Human aldose reductase expression accelerates diabetic atherosclerosis in transgenic mice.

Authors:  Reeba K Vikramadithyan; Yunying Hu; Hye-Lim Noh; Chien-Ping Liang; Kellie Hallam; Alan R Tall; Ravichandran Ramasamy; Ira J Goldberg
Journal:  J Clin Invest       Date:  2005-08-25       Impact factor: 14.808

4.  Streptozotocin-Treated High Fat Fed Mice: A New Type 2 Diabetes Model Used to Study Canagliflozin-Induced Alterations in Lipids and Lipoproteins.

Authors:  Tian Yu; Mitchell J Sungelo; Ira J Goldberg; Hong Wang; Robert H Eckel
Journal:  Horm Metab Res       Date:  2017-04-10       Impact factor: 2.936

5.  Relation of cardiovascular risk factors to atherosclerosis in type III hyperlipoproteinemia.

Authors:  G Feussner; A Wagner; R Ziegler
Journal:  Hum Genet       Date:  1993-09       Impact factor: 4.132

6.  Reduced atherogenesis in cholesterol-fed diabetic rabbits. Giant lipoproteins do not enter the arterial wall.

Authors:  B G Nordestgaard; S Stender; K Kjeldsen
Journal:  Arteriosclerosis       Date:  1988 Jul-Aug

7.  Transcriptional regulation of the apoC-III gene by insulin in diabetic mice: correlation with changes in plasma triglyceride levels.

Authors:  M Chen; J L Breslow; W Li; T Leff
Journal:  J Lipid Res       Date:  1994-11       Impact factor: 5.922

Review 8.  Pros and Cons of Aspirin for the Primary Prevention of Cardiovascular Events: A Secondary Study of Trial Sequential Analysis.

Authors:  Binghao Zhao; Qian Wu; Li Wang; Chen Liao; Yifei Dong; Jingsong Xu; Yiping Wei; Wenxiong Zhang
Journal:  Front Pharmacol       Date:  2021-01-14       Impact factor: 5.810

9.  Effects of prandial versus fasting glycemia on cardiovascular outcomes in type 2 diabetes: the HEART2D trial.

Authors:  Itamar Raz; Peter W F Wilson; Krzysztof Strojek; Irina Kowalska; Velimir Bozikov; Anselm K Gitt; György Jermendy; Barbara N Campaigne; Lisa Kerr; Zvonko Milicevic; Scott J Jacober
Journal:  Diabetes Care       Date:  2009-03       Impact factor: 19.112

View more
  19 in total

Review 1.  Microvascular Inflammation and Cardiovascular Prevention: The Role of Microcirculation as Earlier Determinant of Cardiovascular Risk.

Authors:  Alessandro Mengozzi; Nicola Riccardo Pugliese; Stefano Masi; Agostino Virdis; Stefano Taddei
Journal:  High Blood Press Cardiovasc Prev       Date:  2021-12-02

2.  Clinical variable-based cluster analysis identifies novel subgroups with a distinct genetic signature, lipidomic pattern and cardio-renal risks in Asian patients with recent-onset type 2 diabetes.

Authors:  Jiexun Wang; Jian-Jun Liu; Resham L Gurung; Sylvia Liu; Janus Lee; Yiamunaa M; Keven Ang; Yi Ming Shao; Justin I-Shing Tang; Peter I Benke; Federico Torta; Markus R Wenk; Subramaniam Tavintharan; Wern Ee Tang; Chee Fang Sum; Su Chi Lim
Journal:  Diabetologia       Date:  2022-06-28       Impact factor: 10.460

Review 3.  The Remnant Lipoprotein Hypothesis of Diabetes-Associated Cardiovascular Disease.

Authors:  Karin E Bornfeldt
Journal:  Arterioscler Thromb Vasc Biol       Date:  2022-05-26       Impact factor: 10.514

4.  Diabetes Suppresses Glucose Uptake and Glycolysis in Macrophages.

Authors:  Yunosuke Matsuura; Masami Shimizu-Albergine; Shelley Barnhart; Farah Kramer; Cheng-Chieh Hsu; Vishal Kothari; Jingjing Tang; Sina A Gharib; Jenny E Kanter; E Dale Abel; Rong Tian; Baohai Shao; Karin E Bornfeldt
Journal:  Circ Res       Date:  2022-02-16       Impact factor: 23.213

Review 5.  Potential Mechanisms and Effects of Chinese Medicines in Treatment of Diabetic Atherosclerosis by Modulating NLRP3 Inflammasome: A Narrative Review.

Authors:  Jia-Yao Yuan; Yu Fu; Zhi-Hai Feng; Feng Sang; Ming-Yi Shao; Lei-Lei Li
Journal:  Chin J Integr Med       Date:  2022-05-04       Impact factor: 2.626

Review 6.  Emerging Role of LncRNA Regulation for NLRP3 Inflammasome in Diabetes Complications.

Authors:  Xiaolin Lu; Qihong Tan; Jianyong Ma; Jing Zhang; Peng Yu
Journal:  Front Cell Dev Biol       Date:  2022-01-12

7.  Combined berberine and probiotic treatment as an effective regimen for improving postprandial hyperlipidemia in type 2 diabetes patients: a double blinded placebo controlled randomized study.

Authors:  Shujie Wang; Huahui Ren; Huanzi Zhong; Xinjie Zhao; Changkun Li; Jing Ma; Xuejiang Gu; Yaoming Xue; Shan Huang; Jialin Yang; Li Chen; Gang Chen; Shen Qu; Jun Liang; Li Qin; Qin Huang; Yongde Peng; Qi Li; Xiaolin Wang; Yuanqiang Zou; Zhun Shi; Xuelin Li; Tingting Li; Huanming Yang; Shenghan Lai; Guowang Xu; Junhua Li; Yifei Zhang; Yanyun Gu; Weiqing Wang
Journal:  Gut Microbes       Date:  2022 Jan-Dec

Review 8.  AGEs-Induced and Endoplasmic Reticulum Stress/Inflammation-Mediated Regulation of GLUT4 Expression and Atherogenesis in Diabetes Mellitus.

Authors:  Marisa Passarelli; Ubiratan Fabres Fabres Machado
Journal:  Cells       Date:  2021-12-29       Impact factor: 6.600

Review 9.  Metformin in cardiovascular diabetology: a focused review of its impact on endothelial function.

Authors:  Yu Ding; Yongwen Zhou; Ping Ling; Xiaojun Feng; Sihui Luo; Xueying Zheng; Peter J Little; Suowen Xu; Jianping Weng
Journal:  Theranostics       Date:  2021-09-09       Impact factor: 11.556

10.  Effect and safety of traditional Chinese exercises for patients with type 2 diabetes: A protocol for systematic review and network meta-analysis.

Authors:  Lijuan Zou; Linfeng Lei; Chuifeng Kong; Peiying Yu; Jiazhou Li; Hua-Shan Pan
Journal:  Medicine (Baltimore)       Date:  2021-12-23       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.